Cargando…
A multi-hit therapeutic nanoplatform for hepatocellular carcinoma: Dual stimuli-responsive drug release, dual-modal imaging, and in situ oxygen supply to enhance synergistic therapy
Nanomedicine has been widely studied for the diagnosis and treatment of hepatocellular carcinoma (HCC). How to synthesize a nanoplatform possessing a high synergistic therapeutic efficacy remains a challenge in this emerging research field. In this study, a convenient all-in-one therapeutic nanoplat...
Autores principales: | Chen, Taiying, Tam, Ngalei, Mao, Yu, Sun, Chengjun, Wang, Zekang, Hou, Yuchen, Xia, Wuzheng, Yu, Jia, Wu, Linwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278082/ https://www.ncbi.nlm.nih.gov/pubmed/35847375 http://dx.doi.org/10.1016/j.mtbio.2022.100338 |
Ejemplares similares
-
A Leaking-Proof Theranostic Nanoplatform for Tumor-Targeted and Dual-Modality Imaging-Guided Photodynamic Therapy
por: Jin, Duo, et al.
Publicado: (2023) -
Dual-Ligand Synergistic Targeting Anti-Tumor Nanoplatforms with Cascade-Responsive Drug Release
por: Luo, Fang, et al.
Publicado: (2023) -
Dual Imaging Gold Nanoplatforms for Targeted Radiotheranostics
por: Silva, Francisco, et al.
Publicado: (2020) -
Dual-stimuli responsive smart nanoprobe for precise diagnosis and synergistic multi-modalities therapy of superficial squamous cell carcinoma
por: Zhang, Peisen, et al.
Publicado: (2023) -
Polydopamine-Based “Four-in-One” Versatile Nanoplatforms for Targeted Dual Chemo and Photothermal Synergistic Cancer Therapy
por: Liu, Gan, et al.
Publicado: (2019)